Literature DB >> 18500474

[Patient education in the early treatment of ankylosing spondylitis and related forms of spondyloarthritis].

Inge Ehlebracht-König1, Angelika Bönisch.   

Abstract

Patients with early spondyloarthritis often suffer from uncertainty regarding to their disease and the future development, sometimes fear of the future is to the fore. Patients with rheumatic diseases need a comprehensive and interdisciplinary treatment. In this connection patient education takes the part to lead patients to a better self-management. The goals of patient education are: to increase knowledge and interoception, to influence attitudes and self-efficacy and in addition to improve the disease or health behaviour. The study group "patient education" of the German Society of Rheumatology (DGRh) developed several education programmes, which methods and topics are based on behavioural science. The program for patients with spondyloarthritis is topic entered and close to patients needs. It is an interdisciplinary course, carried out by a qualified education team. The course contains 6 modules each lasting 90 minutes. The efficacy has been proved in different levels as well as return to work, economic advantages have been shown. Particularly patients with early spondyloarthritis and noticeable scores in the self-assessments (BASDAI, FFbH-R, AHI) profited from the education course.

Entities:  

Mesh:

Year:  2008        PMID: 18500474     DOI: 10.1007/s10354-008-0525-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  3 in total

Review 1.  Four psychosocial theories and their application to patient education and clinical practice.

Authors:  V M Gonzalez; J Goeppinger; K Lorig
Journal:  Arthritis Care Res       Date:  1990-09

2.  [Hannover Functional Questionnaire in ambulatory diagnosis of functional disability caused by backache].

Authors:  T Kohlmann; H Raspe
Journal:  Rehabilitation (Stuttg)       Date:  1996-02       Impact factor: 1.113

3.  [The BASDAI-D--an instrument to defining disease status in ankylosing spondylitis and related diseases].

Authors:  A Bönisch; I Ehlebracht-König
Journal:  Z Rheumatol       Date:  2003-06       Impact factor: 1.372

  3 in total
  2 in total

1.  [Advice for patients diagnosed with ankylosing spondylitis: results of a representative patient survey in Germany].

Authors:  E Feldtkeller; L Hammel; C Brenneis; I-H Song; M Rudwaleit
Journal:  Z Rheumatol       Date:  2011-07       Impact factor: 1.372

2.  [EULAR recommendations for patient education of people with inflammatory arthritis. Translation and evaluation in Germany].

Authors:  J Patermann; I Ehlebracht-König; G Lind-Albrecht; E Genth; A Reusch; R Küffner; U Müller-Ladner; J Braun
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.